The radial access is a viable alternative in infarction complicated with cardiogenic shock

Original title: Arterial access site utilization in cardiogenic shock in the United Kingdom: Is radial access feasible? Reference: Mamas A. Mamas, et al. Am Heart J 2014;167:900-08

Cardiogenic shock in the context of acute myocardial infarction is associated with high mortality, and represents approximately 10% of major bleeding complications. Radial Access reduces mortality mainly by reducing bleeding; however, AMI patients complicated with CS undergoing PCI via radial access have only been assessed in small studies. 

This study analyzed 7231 PCI patients hospitalized with AMI complicated with CS, in UK. 1877 (35%) received radial access and 5354 (64%) femoral access.

Baseline characteristics were similar, although those approached by femoral access site were mostly women, diabetic, requiring higher inotropic support or intraaortic balloon counterpulsation and mechanical ventilation.

Global mortality at 30 days was 36.3% for the whole cohort, 24.7% for the radial access group vs. 39.8% for the femoral access group (p<0.01). This difference was also maintained at 12 months.

After propensity score matching was applied to eliminate possible confusing factors, 1402 patients remained in each group for final analysis, and significant lower mortality was observed in the radial Access group at 30 days (22.8% vs 29.9% p<0.001).

Major bleeding rate was also lower in the radial access group. (1.5% vs 3.5%; p<0.0001). The radial access site resulted an independent predictor of lower event rates at 30 days and this benefit was observed at a time when more than 50% of cases at this center were performed via radial approach. 

Conclusion

Even though most of PCI procedure in CS patients in UK are performed via femoral approach, the radial approach has become a feasible alternative for this high risk population in experienced centers.

Editorial Comment

The safety and efficacy of the radial access site had been shown in other scenarios but it had not been correctly assessed for this group of patients. This study has shown the radial access site is safe and can reduce mayor bleeding and mortality also in the difficult scenario of cardiogenic shock. Nevertheless, it demands highly trained, expert operators. 

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation – Buenos Aires

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...